AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,926,336 | -0.7% | 353,502 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $9,997,037 | -5.2% | 353,502 | -25.7% | 0.00% | 0.0% |
| Q2 2022 | $10,547,001 | -26.9% | 475,733 | -4.1% | 0.00% | 0.0% |
| Q1 2022 | $14,435,416 | +113.5% | 495,892 | +141.1% | 0.00% | +200.0% |
| Q4 2021 | $6,760,000 | -50.4% | 205,646 | -30.4% | 0.00% | -66.7% |
| Q3 2021 | $13,640,000 | -36.8% | 295,557 | -24.5% | 0.00% | -40.0% |
| Q2 2021 | $21,581,000 | +54.8% | 391,591 | +45.1% | 0.01% | +66.7% |
| Q1 2021 | $13,938,000 | -43.6% | 269,902 | -52.6% | 0.00% | -50.0% |
| Q4 2020 | $24,691,000 | +26.5% | 569,836 | +2.2% | 0.01% | +20.0% |
| Q3 2020 | $19,517,000 | -60.8% | 557,625 | -40.1% | 0.01% | -64.3% |
| Q2 2020 | $49,818,000 | +34.5% | 931,521 | -10.8% | 0.01% | +7.7% |
| Q1 2020 | $37,036,000 | -25.7% | 1,043,854 | 0.0% | 0.01% | -7.1% |
| Q4 2019 | $49,844,000 | +211.5% | 1,043,854 | +111.4% | 0.01% | +180.0% |
| Q3 2019 | $16,001,000 | -23.2% | 493,854 | +18.2% | 0.01% | -16.7% |
| Q2 2019 | $20,841,000 | -26.0% | 417,825 | 0.0% | 0.01% | -33.3% |
| Q1 2019 | $28,178,000 | +46.3% | 417,825 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $19,267,000 | -31.8% | 417,825 | +14.0% | 0.01% | -22.2% |
| Q3 2018 | $28,262,000 | -8.4% | 366,476 | 0.0% | 0.01% | -18.2% |
| Q2 2018 | $30,868,000 | +3.0% | 366,476 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $29,971,000 | +65.6% | 366,476 | +15.8% | 0.01% | +83.3% |
| Q4 2017 | $18,093,000 | -14.4% | 316,476 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $21,125,000 | -33.5% | 316,476 | -48.8% | 0.01% | -38.5% |
| Q2 2017 | $31,777,000 | -13.4% | 617,634 | -1.7% | 0.01% | -13.3% |
| Q1 2017 | $36,676,000 | +344.8% | 628,027 | +217.8% | 0.02% | +275.0% |
| Q4 2016 | $8,246,000 | -26.3% | 197,611 | -10.9% | 0.00% | -20.0% |
| Q3 2016 | $11,184,000 | +20.4% | 221,697 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $9,288,000 | +127.1% | 221,697 | +120.1% | 0.00% | +100.0% |
| Q1 2016 | $4,090,000 | -59.5% | 100,731 | -35.3% | 0.00% | -60.0% |
| Q4 2015 | $10,102,000 | -15.4% | 155,610 | -7.9% | 0.01% | -16.7% |
| Q3 2015 | $11,934,000 | -46.9% | 169,049 | -16.4% | 0.01% | -45.5% |
| Q2 2015 | $22,482,000 | +83.4% | 202,293 | +55.6% | 0.01% | +83.3% |
| Q1 2015 | $12,259,000 | – | 129,994 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |